AbCellera Biologics Inc.
USD8.12
+0.74 (+10.03%)
CEO
Carl Hansen
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$7.56
Prev. Close
$7.38
Day Low
$7.39
Day High
$8.42
52W Low
$2.75
52W High
$8.42
Market Cap
$2.48B
Volume
14.27M
| -5.3 |
| 31 Dec 2023 | FY | 100.0% | -385.0% | -12.7% | -9.8% | 0.07 | 7.33 | -11.3 |
| 31 Dec 2022 | FY | 86.3% | 32.7% | 12.9% | 10.3% | 0.07 | 8.67 | 18.2 |
| 31 Dec 2021 | FY | 87.9% | 40.9% | 15.0% | 11.6% | 0.04 | 7.70 | 25.7 |
| 31 Dec 2020 | FY | 88.4% | 51.0% | 14.3% | 11.8% | 0.01 | 7.86 | 90.6 |
| 31 Dec 2019 | FY | 100.0% | -19.0% | -21.6% | -9.4% | 0.67 | 1.60 | -5738.5 |
| 31 Dec 2018 | FY | 100.0% | 3.5% | 2.7% | 1.4% | 0.30 | 2.36 | 28795.0 |
| -28.6 |
| 30 Sept 2025 | Q3 | 100.0% | -637.8% | -5.9% | -4.2% | 0.15 | 10.10 | -6.6 |
| 30 Jun 2025 | Q2 | 100.0% | -203.3% | -3.4% | -2.5% | 0.14 | 11.07 | -7.4 |
| 31 Mar 2025 | Q1 | 100.0% | -1077.2% | -4.5% | -3.4% | 0.07 | 10.15 | -3.6 |
| 31 Dec 2024 | Q4 | 100.0% | -677.4% | -3.2% | -2.5% | 0.06 | 9.81 | -6.3 |
| 30 Sept 2024 | Q3 | 100.0% | -785.4% | -4.7% | -3.7% | 0.07 | 9.34 | -3.8 |
| 30 Jun 2024 | Q2 | 100.0% | -504.3% | -3.3% | -2.6% | 0.06 | 10.96 | -5.5 |
| 31 Mar 2024 | Q1 | 100.0% | -408.0% | -3.6% | -2.8% | 0.07 | 7.76 | -8.0 |
| 31 Dec 2023 | Q4 | 100.0% | -513.7% | -4.1% | -3.2% | 0.07 | 7.33 | -8.8 |